{"id":"cggv:a493a4c4-3a9f-431a-a68e-d90d9a11b6f0v1.0","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"cggv:a493a4c4-3a9f-431a-a68e-d90d9a11b6f0_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10007","date":"2020-02-06T17:20:31.658Z","role":"Approver"},{"id":"cggv:a493a4c4-3a9f-431a-a68e-d90d9a11b6f0_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10007","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"evidence":[{"id":"cggv:a493a4c4-3a9f-431a-a68e-d90d9a11b6f0_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:a493a4c4-3a9f-431a-a68e-d90d9a11b6f0_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:e5128ace-d1ad-40a9-97d8-657408a2d7ca","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:7240fb87-f731-4355-8438-29e6c897fd55","type":"Finding","demonstrates":{"id":"cg:GeneExpressionA"},"dc:description":"RT-PCR revealed strong expresson of OSBPL2 in mouse cochlea (as well as brain). Immunohistochemical localization showed Osbpl2 in the stria vascularis, spiral ganglion, IHCs and OHCs of mouse cochlea.","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/25077649","type":"dc:BibliographicResource","dc:abstract":"Various forms of hearing loss have genetic causes, but many of the responsible genes have not yet been identified. Here, we describe a large seven-generation Chinese family with autosomal dominant nonsyndromic hearing loss that has been excluded as being caused by known deafness gene mutations associated with autosomal dominant nonsyndromic hearing loss with the aim of identifying a novel causative gene involved in deafness.","dc:creator":"Xing G","dc:date":"2015","dc:title":"Identification of OSBPL2 as a novel candidate gene for progressive nonsyndromic hearing loss by whole-exome sequencing."},"rdfs:label":"Xing-expression (inner ear)"}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"cggv:9e8d82d0-49ef-4671-8ffe-86a2ab09df68","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:901dc35d-22c5-46f8-82da-8e1b96a9e7fe","type":"Finding","demonstrates":{"id":"cg:GeneExpressionA"},"dc:description":"RT-PCR of mouse and rat cochlea showed presence of OSBPL2 transcript in both. Immunofluorescent staining of mouse organ of Corti showed Osbpl2 present in both OHCs and IHCs. No difference was found in Osbpl2 levels between P20 and 6 month old mice.","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/25759012","type":"dc:BibliographicResource","dc:abstract":"Early-onset hearing loss is mostly of genetic origin. The complexity of the hearing process is reflected by its extensive genetic heterogeneity, with probably many causative genes remaining to be identified. Here, we aimed at identifying the genetic basis for autosomal dominant non-syndromic hearing loss (ADNSHL) in a large German family.","dc:creator":"Thoenes M","dc:date":"2015","dc:title":"OSBPL2 encodes a protein of inner and outer hair cell stereocilia and is mutated in autosomal dominant hearing loss (DFNA67)."},"rdfs:label":"Mouse and rat cochlea expression"}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"cggv:a493a4c4-3a9f-431a-a68e-d90d9a11b6f0_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:9e268618-6a34-4173-8016-3b5584deb30c","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:00458f7a-328f-47b1-8914-0f684272cff6","type":"Finding","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"},"dc:description":"Both humans and pigs exhibit similar types and levels of hearing loss. This also confirms the dual phenotypes seen in humans with mutations in OSBPL2 (progressive hearing loss and hypercholesterolemia).","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/31451425","type":"dc:BibliographicResource","dc:abstract":"Oxysterol binding protein like 2 (OSBPL2), an important regulator in cellular lipid metabolism and transport, was identified as a novel deafness-causal gene in our previous work. To resemble the phenotypic features of OSBPL2 mutation in animal models and elucidate the potential genotype-phenotype associations, the OSBPL2-disrupted Bama miniature (BM) pig model was constructed using CRISPR/Cas9-mediated gene editing, somatic cell nuclear transfer (SCNT) and embryo transplantation approaches, and then subjected to phenotypic characterization of auditory function and serum lipid profiles. The OSBPL2-disrupted pigs displayed progressive hearing loss (HL) with degeneration/apoptosis of cochlea hair cells (HCs) and morphological abnormalities in HC stereocilia, as well as hypercholesterolaemia. High-fat diet (HFD) feeding aggravated the development of HL and led to more severe hypercholesterolaemia. The dual phenotypes of progressive HL and hypercholesterolaemia resembled in OSBPL2-disrupted pigs confirmed the implication of OSBPL2 mutation in nonsydromic hearing loss (NSHL) and contributed to the potential linkage between auditory dysfunction and dyslipidaemia/hypercholesterolaemia.","dc:creator":"Yao J","dc:date":"2019","dc:title":"OSBPL2-disrupted pigs recapitulate dual features of human hearing loss and hypercholesterolaemia."},"rdfs:label":"Bama miniature pig model"}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1,"dc:description":"The pig model was a homozygous knockout model not heterozygous even though this has been associated with a heterozygous condition."}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"cggv:a493a4c4-3a9f-431a-a68e-d90d9a11b6f0_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:a493a4c4-3a9f-431a-a68e-d90d9a11b6f0_seg_el","type":"EvidenceLine","specifiedBy":"GeneValiditySegregationEvidencCriteria","strengthScore":3},{"id":"cggv:a493a4c4-3a9f-431a-a68e-d90d9a11b6f0_ad_other_el","type":"EvidenceLine","evidence":[{"id":"cggv:46ebda13-5443-4c02-830a-7737bdaf4703_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:1759ce0a-c93a-42e6-af17-f8c7cb2fc79f","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","phenotypeFreeText":"bilateral symmetric moderate sensorineural hearing loss","phenotypes":"obo:HP_0000408","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"cggv:46ebda13-5443-4c02-830a-7737bdaf4703_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:003e110a-69cb-4d57-a6df-b56f3e41582e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000020.11:g.62279248C>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA409542766"}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25077649"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25077649","rdfs:label":"Xing-2"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0,"dc:description":"Proband was identified upon screening of 452 sporadic NSHL cases. Computational modeling predicts a change of shape to the protein in the predicted ligand-binding domain. No score"}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":0},{"id":"cggv:a493a4c4-3a9f-431a-a68e-d90d9a11b6f0_ad_null_el","type":"EvidenceLine","evidence":[{"id":"cggv:fb22e57b-c6bd-4f89-920c-3f39567412ad_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:fb53805b-4b14-46b4-96e5-34a8f54a53d9","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","phenotypeFreeText":"bilateral sensorineural hearing loss, mostly with onset in early second decade of life, however age of onset varied between 10 and 30. Generally varied progression.","phenotypes":"obo:HP_0000408","previousTesting":true,"previousTestingDescription":"GJB2 negative, and negative for 66 known deafness genes.","sex":"UnknownEthnicity","variant":{"id":"cggv:fb22e57b-c6bd-4f89-920c-3f39567412ad_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:6d047b8e-258b-40ea-a9cb-f255242c5234","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_144498.2(OSBPL2):c.141_142delTG (p.Arg50Alafs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/190111"}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25759012"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25759012","rdfs:label":"Theones 1 Proband"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1,"dc:description":"Family was of German descent. One additional 39 y-o family member (IV:12) carried the variant but only reports worse hearing in times of stress. Not included in segregation count. No evidence provided for LoF, so downgraded to 1"},{"id":"cggv:9d7e069c-250a-419c-9683-eaa1bb62e418_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:6a8970ca-a70a-4fd3-bcf4-e7900235038e","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":44,"detectionMethod":"WGS performed on 5 members of the family (3 affected and 2 unaffected). Sanger sequencing used to validate the co-segregation of the candidate pathogenic variant. Linkage analysis also performed using Perl based Merlin tools and combined high throughput sequencing data in the family and allelic frequency of Chinese population in HapMap database. All SNPs and indels were filtered through the 1000 Genomes Project and candidate genes were further screened. The results were screened by in house Novogene algorithm and combined with dbSNP, ExAC. This narrowed it down to OSBPL2 and matched the localization and was consistent with the peak detected in chromosome 20 in the linkage analysis.","firstTestingMethod":"Whole genome shotgun sequencing","phenotypeFreeText":"moderate SNHL","phenotypes":["obo:HP_0008596","obo:HP_0001730"],"previousTesting":true,"previousTestingDescription":"Exome capture sequencing on 127 known deafness genes failed to identify any pathogenic mutations","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:9d7e069c-250a-419c-9683-eaa1bb62e418_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:35fc2f02-c1ca-42fd-907d-82bec0cf65dc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363878.1(OSBPL2):c.-209_-208del (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA915940532"}},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/30894143","type":"dc:BibliographicResource","dc:abstract":"To investigate the clinical features and the underlying causal gene of a family with hereditary late-onset deafness in Inner Mongolia of China, and to provide evidence for the early genetic screening and diagnosis of this disease.","dc:creator":"Wu N","dc:date":"2019","dc:title":"A novel pathogenic variant in OSBPL2 linked to hereditary late-onset deafness in a Mongolian family."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30894143","rdfs:label":"V:9"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":2,"dc:description":"Scored 2 points and upgraded due to segregation in large family in a relatively constrained gene. Remaining consistent with upgrade of previous null variant in Xing 2015"},{"id":"cggv:844cf61a-e9e9-4664-a090-71ae3f374993_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:62f484e2-fcc8-4646-80fb-394d3467e87b","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"bilateral, mild to profound sensorineural hearing loss. Usually startd at high frequencies at an early age and progressed rapidly to other frequencies at a later age. All but one reported high-frequency tinnitus around onset of HL. No vestibular symptoms. Age of onset varied from 5 to 32 years. Full clinical data available in supp. material","phenotypes":["obo:HP_0000360","obo:HP_0000408"],"previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"cggv:844cf61a-e9e9-4664-a090-71ae3f374993_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:8017f42a-9fd4-45f8-9464-4944596d63be","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_144498.2(OSBPL2):c.156_157delTC (p.Gln53Argfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/190110"}},"alleleOrigin":{"id":"obo:GENO_0000888"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25077649"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25077649","rdfs:label":"Xing-1 Proband"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":2,"dc:description":"Family was of Han Chinese descent. Pedigree spanned 7 generations and included 199 members. 45 living members reported to have HL, with 25 available for study. 26 unaffected members were available for study. Maxed segregation points.Â WES"}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":8}],"evidenceStrength":"Moderate","sequence":283,"specifiedBy":"GeneValidityCriteria7","strengthScore":10,"subject":{"id":"cggv:0fee5c0d-acfc-469c-9c75-0c4a9703ea3e","type":"GeneValidityProposition","disease":"obo:MONDO_0019497","gene":"hgnc:15761","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","dc:description":"OSBPL2 was reported with autosomal dominant nonsyndromic hearing loss in 2015 (Xing et al., PMID: 25077649). At least 4 unique variants (missense, frameshift) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 4 probands in 3 publications (PMID: 25077649, 25759012, 30894143). Variants in this gene segregated with disease in 31 additional family members. This gene-disease association is supported by animal models and expression studies. In summary, there is moderate evidence to support this gene-disease association. While more evidence is needed to establish this association definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Hearing Loss Working Group on 2/6/2020.\n","dc:isVersionOf":{"id":"cggv:a493a4c4-3a9f-431a-a68e-d90d9a11b6f0"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}